As digital health evolves, many people have become concerned about the potential limitations HIPAA places on technological advancements. Is HIPAA relevant for all digital health services? Join Darshan Kulkarni as he speaks with privacy attorney...
Due to Brexit, the Medicines and Healthcare products Regulatory Agency (MHRA) has had to develop its own procedures separate from the European Medicines Agency (EMA). What new guidance has the MHRA released? Join Darshan Kulkarni as he talks with...
How can bioscience companies foster diversity within their industry? Join Darshan Kulkarni as he talks with entrepreneur Tia Lyles-Williams about the value of diversity within the life sciences. Plus, we’ll talk about the barriers to diversity in...
Life science company Verily has recently launched a new health insurance venture. How might this affect the healthcare industry? In today’s episode, Darshan Kulkarni talks with healthcare lawyer and practice leader Kenneth White about the...
What is an FDA warning letter, and how should your company respond once it has received one? In today's episode, Darshan Kulkarni talks with former FDA inspector Patrick Stone about the auditing process in compounding pharmacies, and how companies...
There is growing pressure being placed on pharmaceutical companies to make their clinical trials more transparent. Despite this pressure, there remain privacy concerns about publicizing clinical research data. How can companies successfully balance...